Key Developments: McKesson Corp (MCK.N)

MCK.N on New York Stock Exchange

222.15USD
2:53pm EDT
Change (% chg)

$1.58 (+0.72%)
Prev Close
$220.57
Open
$221.54
Day's High
$222.87
Day's Low
$220.67
Volume
117,346
Avg. Vol
251,288
52-wk High
$243.61
52-wk Low
$178.30

Search Stocks

Latest Key Developments (Source: Significant Developments)

McKesson Corp declares quarterly dividend
Tuesday, 21 Oct 2014 05:00pm EDT 

McKesson Corp:Declares regular dividend of 24 cents per share on Common Stock.Payable on Jan. 2, 2015, to stockholders of record on Dec. 1.  Full Article

McKesson Corp raises FY 2015 EPS outlook
Thursday, 31 Jul 2014 07:30am EDT 

McKesson Corp:Now expects FY 2015 adjusted earnings per diluted share from continuing operations between $10.50 and $10.90.FY 2015 EPS of $10.66 - Thomson Reuters I/B/E/S.  Full Article

McKesson Corp declares regular dividend
Wednesday, 30 Jul 2014 04:10pm EDT 

McKesson Corp:Declares regular dividend of 24 cents per share on Common Stock.Dividend will be payable on Oct. 1, to stockholders of record on Sept. 2.  Full Article

McKesson extends pharmaceutical distribution agreement with CVS Caremark
Wednesday, 30 Jul 2014 09:00am EDT 

McKesson Corp:Announces a three-year extension of its existing distribution agreement with CVS Caremark through June, 2019.  Full Article

McKesson Corp reaffirms FY 2015 EPS outlook
Wednesday, 25 Jun 2014 08:00am EDT 

McKesson Corp:Reaffirmed its earnings guidance for FY 2015 and the underlying key assumptions provided in its press release of May 12.FY 2015 EPS of $10.66 - Thomson Reuters I/B/E/S.  Full Article

Symphony Technology Group to acquire European Healthcare Software Businesses from McKesson Corp
Monday, 2 Jun 2014 06:00am EDT 

McKesson Corp:Symphony Technology Group announces that it has agreed to acquire several of the European healthcare technology operations of McKesson Corporation (McKesson).These operations include the UK Health and Social Care business, including System C and Liquidlogic, as well as McKesson's software operations in France and the Netherlands.  Full Article

McKesson declares quarterly dividend
Wednesday, 28 May 2014 04:10pm EDT 

McKesson Corp:Declares a regular dividend of twenty-four cents per share on Common Stock.Payable on July 1, to stockholders of record on June 9.  Full Article

McKesson Corp gives FY 2015 EPS guidance in line with analysts' estimates
Monday, 12 May 2014 04:10pm EDT 

McKesson Corp:Expects adjusted earnings per diluted share between $10.40 and $10.80 for FY 2015.FY 2015 EPS of $10.58 - Thomson Reuters I/B/E/S.  Full Article

McKesson Corp launches takeover offer for remaining Celesio shares
Friday, 28 Feb 2014 09:05am EST 

McKesson Corp:Launched voluntary public takeover offer for remaining outstanding shares of Celesio AG through its indirect wholly-owned subsidiary Dragonfly GmbH & Co. KGaA.There are no closing conditions in relation to the Takeover Offer.McKesson exceeds 75 pct ownership of Celesio shares on fully diluted basis.  Full Article

McKesson Corp and Rite Aid expand distribution agreement
Tuesday, 18 Feb 2014 08:45am EST 

McKesson Corp and Rite Aid Corp:Signs of an expanded distribution agreement to include both brand and generic pharmaceuticals.Says new five-year agreement, which extends through March 2019, creates efficiencies for both companies by leveraging the strength.Says agreement leverages the strength of Rite Aid national drugstore chains in the United States and McKesson as a leader in pharmaceutical sourcing and supply chain management.  Full Article

Photo

Allergan CEO, fresh off one deal, sets sights on others

NEW YORK - Allergan plc CEO Brent Saunders is ready to put the $36 billion his company will net from the sale of its generics business to Teva Pharmaceutical Industries Ltd to work, possibly with another large, "transformational" merger.

Search Stocks